[go: up one dir, main page]

NO20072499L - Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser - Google Patents

Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Info

Publication number
NO20072499L
NO20072499L NO20072499A NO20072499A NO20072499L NO 20072499 L NO20072499 L NO 20072499L NO 20072499 A NO20072499 A NO 20072499A NO 20072499 A NO20072499 A NO 20072499A NO 20072499 L NO20072499 L NO 20072499L
Authority
NO
Norway
Prior art keywords
methods
receptor binding
compositions
applications
melanocortin receptor
Prior art date
Application number
NO20072499A
Other languages
English (en)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of NO20072499L publication Critical patent/NO20072499L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Melanocortin reseptorbindende antistoff etterlikner polypeptider er beskrevet. Polynukleotider som koder for disse polypeptidene, celler omfattende disse polynukleotidene eller som uttrykker antistoff etterliknerne, fremgangsmåter for å fremstille og anvende de foregående er også beskrevet.
NO20072499A 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser NO20072499L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
NO20072499L true NO20072499L (no) 2007-07-16

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072499A NO20072499L (no) 2004-10-25 2007-05-15 Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser

Country Status (29)

Country Link
US (1) US20060105951A1 (no)
EP (1) EP1812046B1 (no)
JP (1) JP2008517605A (no)
KR (1) KR101255140B1 (no)
CN (1) CN101437540B (no)
AT (1) ATE501731T1 (no)
AU (1) AU2005299440B2 (no)
BR (1) BRPI0518411A2 (no)
CA (1) CA2585287A1 (no)
CY (1) CY1111486T1 (no)
DE (1) DE602005026970D1 (no)
DK (1) DK1812046T3 (no)
EA (1) EA200700944A1 (no)
EC (1) ECSP077416A (no)
ES (1) ES2363023T3 (no)
HK (1) HK1106445A1 (no)
HR (1) HRP20110405T1 (no)
IL (1) IL182683A0 (no)
MA (1) MA28943B1 (no)
ME (1) ME01234B (no)
MX (1) MX2007004974A (no)
NO (1) NO20072499L (no)
PL (1) PL1812046T3 (no)
PT (1) PT1812046E (no)
RS (1) RS51789B (no)
SI (1) SI1812046T1 (no)
TN (1) TNSN07157A1 (no)
WO (1) WO2006047535A2 (no)
ZA (1) ZA200704260B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en) 2008-06-09 2015-02-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US20090305960A1 (en) * 2008-06-09 2009-12-10 Palatin Technologies, Inc Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
EA020959B1 (ru) 2009-06-08 2015-03-31 Палатин Текнолоджиз, Инк. Пептиды, специфичные к меланокортиновым рецепторам
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
MX2012005862A (es) 2009-11-23 2012-09-07 Palatin Technologies Inc Peptidos ciclicos especificos del receptor de melanocortina-1.
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137340A4 (en) 1998-12-09 2005-12-21 Eleanor Roosevelt Inst COMPOSITION AND METHODS FOR REGULATION OF BODY WEIGHT AND ASSOCIATED PATHOLOGIES
EP1303625A2 (en) * 2000-07-14 2003-04-23 Zycos Inc. Alpha-msh related compounds and methods of use
CA2490409A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
BR0312276A (pt) * 2002-06-28 2005-04-26 Centocor Inc Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
WO2005097175A2 (en) * 2004-03-31 2005-10-20 Centocor, Inc. Human glp-1 mimetibodies, compositions, methods and uses

Also Published As

Publication number Publication date
US20060105951A1 (en) 2006-05-18
ECSP077416A (es) 2007-05-30
ME01234B (me) 2013-06-20
HRP20110405T1 (hr) 2011-06-30
WO2006047535A2 (en) 2006-05-04
PL1812046T3 (pl) 2011-08-31
ZA200704260B (en) 2009-03-25
RS51789B (en) 2011-12-31
KR101255140B1 (ko) 2013-04-22
DK1812046T3 (da) 2011-06-06
EP1812046A4 (en) 2009-11-11
SI1812046T1 (sl) 2011-06-30
AU2005299440A1 (en) 2006-05-04
JP2008517605A (ja) 2008-05-29
MA28943B1 (fr) 2007-10-01
ATE501731T1 (de) 2011-04-15
EP1812046A2 (en) 2007-08-01
EP1812046B1 (en) 2011-03-16
TNSN07157A1 (en) 2008-11-21
IL182683A0 (en) 2007-09-20
ES2363023T3 (es) 2011-07-19
BRPI0518411A2 (pt) 2008-11-18
PT1812046E (pt) 2011-06-28
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
DE602005026970D1 (de) 2011-04-28
CN101437540A (zh) 2009-05-20
KR20070085416A (ko) 2007-08-27
CN101437540B (zh) 2012-12-19
MX2007004974A (es) 2007-10-17
CA2585287A1 (en) 2006-05-04
AU2005299440B2 (en) 2011-12-15
WO2006047535A3 (en) 2008-09-04
HK1106445A1 (en) 2008-03-14

Similar Documents

Publication Publication Date Title
NO20072499L (no) Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
MX2008000230A (es) Proteinas de enlace il-6.
DK1864132T3 (da) Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
WO2007079218A3 (en) Metalloproteinase binding proteins
DK2390267T3 (da) Stabile og opløselige antistoffer, der hæmmer TNF(alfa)
WO2006055689A3 (en) Protein scaffolds and uses thereof
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
LT3339445T (lt) Baltymai, suryšantys interleukiną 13
EP1718751A4 (en) NEW BACILLUS THURINGIENSIS CRYSTAL POLYPEPTIDES, POLYNUCLEOTIDES, AND COMPOSITIONS THEREOF
DK1871805T3 (da) Antigenbindende molekyler der binder egfr, vektorer der koder derfor, og anvendelser deraf
EP1940217A4 (en) ISOLATED POLYPEPTIDES, POLYNUCLEOTIDES ENCODING THESE, TRANSGENIC PLANTS EXPRESSING THESE AND METHODS USING SAME
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
IL188611A0 (en) Sp1 polypeptides, modified sp1 polypeptides and uses thereof
DK1844072T3 (da) MHC-oligomer og fremgangsmåde til fremstilling deraf
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
MX2007011411A (es) Interaccion rage/diaphanous y composiciones relacionadas y metodos.
TW200711846A (en) Composite materials and methods of making the same
ES1054865U (es) Junta vertical para bloque ceramico utilizado en fabrica armada mediante costillas
ITTR20050009U1 (it) Quaderno, quadernone, blocco o album con copertina personalizzata.
ITTR20050010U1 (it) Quaderno, quadernone, blocco o album con copertina personalizzata.
IL242077A0 (en) sp1 type polypeptides and the like, and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application